Developing Viability Index for Machine Perfused Livers
Development of a Liver Viability Index for Transplantation
Sponsor: Brigham and Women's Hospital
Listed as NCT03694691, this NA trial focuses on Liver Cirrhoses and remains actively recruiting participants. Sponsored by Brigham and Women's Hospital, it has been updated 10 times since 2018, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
Dec 2025 — Present [monthly]
Recruiting NA
-
Dec 2024 — Dec 2025 [monthly]
Recruiting NA
-
Sep 2024 — Dec 2024 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Nov 2023 — Jul 2024 [monthly]
Recruiting NA
▶ Show 5 earlier versions
-
Oct 2022 — Nov 2023 [monthly]
Recruiting NA
-
Oct 2021 — Oct 2022 [monthly]
Recruiting NA
-
Jan 2021 — Oct 2021 [monthly]
Recruiting NA
-
Apr 2019 — Jan 2021 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Nov 2018 — Apr 2019 [monthly]
Not Yet Recruiting NA
First recorded
Oct 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Brigham and Women's Hospital
- Massachusetts General Hospital
- Shriners Hospitals for Children
For direct contact, visit the study record on ClinicalTrials.gov .